Babak, O. Y., & Lapshyna, K. A. (2020). The fibroblasts growth factor 21 study in patients with non-alcoholic fatty liver disease and hypertension comorbidities. Zaporozhye Medical Journal, 22(2). https://doi.org/10.14739/2310-1210.2020.2.200572